Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 53

1.

Oxaliplatin-Induced Leukocytoclastic Vasculitis under Adjuvant Chemotherapy for Colorectal Cancer: Two Cases of a Rare Adverse Event.

Quack H, Erpenbeck L, Wolff HA, Sprenger T, Seitz CS, Schön MP, Neumann S, Stanek K, Ghadimi BM, Michels B, Middel P, Schaefer IM, Liersch T, Conradi LC.

Case Rep Oncol. 2013 Dec 11;6(3):609-15. doi: 10.1159/000357166. eCollection 2013 Sep.

PMID:
24474925
[PubMed]
Free PMC Article
2.

Preoperative chemoradiation therapy with capecitabine/oxaliplatin and cetuximab in rectal cancer: long-term results of a prospective phase 1/2 study.

Fokas E, Conradi L, Weiss C, Sprenger T, Middel P, Rau T, Dellas K, Kitz J, Rödel F, Sauer R, Rüschoff J, Beissbarth T, Arnold D, Ghadimi BM, Rödel C, Liersch T.

Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):992-9. doi: 10.1016/j.ijrobp.2013.09.011. Epub 2013 Oct 24.

PMID:
24210078
[PubMed - indexed for MEDLINE]
3.

Evaluation of EGFR protein expression by immunohistochemistry using H-score and the magnification rule: re-analysis of the SATURN study.

Mazières J, Brugger W, Cappuzzo F, Middel P, Frosch A, Bara I, Klingelschmitt G, Klughammer B.

Lung Cancer. 2013 Nov;82(2):231-7. doi: 10.1016/j.lungcan.2013.07.016. Epub 2013 Aug 7.

PMID:
23972450
[PubMed - indexed for MEDLINE]
Free Article
4.

Frequency of HER-2 positivity in rectal cancer and prognosis.

Conradi LC, Styczen H, Sprenger T, Wolff HA, Rödel C, Nietert M, Homayounfar K, Gaedcke J, Kitz J, Talaulicar R, Becker H, Ghadimi M, Middel P, Beissbarth T, Rüschoff J, Liersch T.

Am J Surg Pathol. 2013 Apr;37(4):522-31. doi: 10.1097/PAS.0b013e318272ff4d.

PMID:
23282976
[PubMed - indexed for MEDLINE]
5.

Reproducibility of immunohistochemical scoring for epidermal growth factor receptor expression in non-small cell lung cancer: round robin test.

Rüschoff J, Kerr KM, Grote HJ, Middel P, von Heydebreck A, Alves VA, Baldus SE, Büttner R, Carvalho L, Fink L, Jochum W, Lo AW, López-Ríos F, Marx A, Molina TJ, Olszewski WT, Rieker RJ, Volante M, Thunnissen E, Wrba F, Celik I, Störkel S.

Arch Pathol Lab Med. 2013 Sep;137(9):1255-61. doi: 10.5858/arpa.2012-0605-OA. Epub 2012 Dec 27.

PMID:
23270410
[PubMed - indexed for MEDLINE]
6.

Pyloric gland adenoma of the cystic duct with malignant transformation: report of a case with a review of the literature.

Schaefer IM, Cameron S, Middel P, Homayounfar K, Schwörer H, Vieth M, Veits L.

BMC Cancer. 2012 Dec 4;12:570. doi: 10.1186/1471-2407-12-570.

PMID:
23206236
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

[Translational research and diagnostics of melanoma].

Rüschoff J, Kleinschmidt M, Middel P.

Pathologe. 2012 Nov;33 Suppl 2:291-5. doi: 10.1007/s00292-012-1661-1. Review. German.

PMID:
22968732
[PubMed - indexed for MEDLINE]
8.

Enrichment of CD133-expressing cells in rectal cancers treated with preoperative radiochemotherapy is an independent marker for metastasis and survival.

Sprenger T, Conradi LC, Beissbarth T, Ermert H, Homayounfar K, Middel P, Rüschoff J, Wolff HA, Schüler P, Ghadimi BM, Rödel C, Becker H, Rödel F, Liersch T.

Cancer. 2013 Jan 1;119(1):26-35. doi: 10.1002/cncr.27703. Epub 2012 Jun 26.

PMID:
22736392
[PubMed - indexed for MEDLINE]
Free Article
9.

[Anal cancer: diagnostic and differential diagnostic issues].

Rüschoff J, Aust A, Middel P, Heinmöller E.

Pathologe. 2011 Jul;32(4):336-44. doi: 10.1007/s00292-011-1440-4. Review. German.

PMID:
21681470
[PubMed - indexed for MEDLINE]
10.

Simultaneous aberrations of single CDKN2A network components and a high Rb phosphorylation status can differentiate subgroups of primary cutaneous B-cell lymphomas.

Kaune KM, Neumann C, Hallermann C, Haller F, Schön MP, Middel P.

Exp Dermatol. 2011 Apr;20(4):331-5. doi: 10.1111/j.1600-0625.2010.01226.x.

PMID:
21410763
[PubMed - indexed for MEDLINE]
11.

[Rare intramuscular haemangioma of the sternocleidomastoid muscle].

Pistor C, Mariss G, Meyer W, Middel P.

HNO. 2011 Apr;59(4):371-4. doi: 10.1007/s00106-010-2196-5. German.

PMID:
21359585
[PubMed - indexed for MEDLINE]
12.

Thymidylate synthase as a prognostic biomarker for locally advanced rectal cancer after multimodal treatment.

Conradi LC, Bleckmann A, Schirmer M, Sprenger T, Jo P, Homayounfar K, Wolff HA, Rothe H, Middel P, Becker H, Ghadimi MB, Beissbarth T, Liersch T.

Ann Surg Oncol. 2011 Sep;18(9):2442-52. doi: 10.1245/s10434-011-1608-4. Epub 2011 Feb 23.

PMID:
21347782
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Chemokine-mediated distribution of dendritic cell subsets in renal cell carcinoma.

Middel P, Brauneck S, Meyer W, Radzun HJ.

BMC Cancer. 2010 Oct 22;10:578. doi: 10.1186/1471-2407-10-578.

PMID:
20969772
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Exophytic benign mixed epithelial stromal tumour of the kidney: case report of a rare tumour entity.

Richter M, Meyer W, Küster J, Middel P.

Diagn Pathol. 2010 Mar 1;5:16. doi: 10.1186/1746-1596-5-16.

PMID:
20193076
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Secondary cutaneous vasculitislike MALT lymphoma with an IGL-MYC fusion.

Kaune KM, Baumgart M, Gesk S, Middel P, Ghadimi BM, Siebert R, Bertsch HP, Schön MP, Neumann C.

Arch Dermatol. 2009 Aug;145(8):955-8. doi: 10.1001/archdermatol.2009.166. No abstract available.

PMID:
19687442
[PubMed - indexed for MEDLINE]
16.

Papular exanthem discloses acute myeloid leukaemia: interphase fluorescence in situ hybridization revealed deletion of p53 and gain at 8q22/8q24/Tel8q without trisomy 8.

Kaune KM, Baumgart M, Schmitke E, Haase D, Middel P, Ghadimi BM, Bertsch HP, Neumann C, Emmert S.

Clin Exp Dermatol. 2010 Mar;35(2):160-4. doi: 10.1111/j.1365-2230.2009.03224.x. Epub 2009 May 5.

PMID:
19438543
[PubMed - indexed for MEDLINE]
17.

[Active surveillance of localized prostate cancer. Significance of prostate core needle biopsies].

Rüschoff J, Middel P, Albers P.

Pathologe. 2008 Sep;29(5):339-47. doi: 10.1007/s00292-008-1013-3. German.

PMID:
18612641
[PubMed - indexed for MEDLINE]
18.

Cathepsin K deficiency partially inhibits, but does not prevent, bone destruction in human tumor necrosis factor-transgenic mice.

Schurigt U, Hummel KM, Petrow PK, Gajda M, Stöckigt R, Middel P, Zwerina J, Janik T, Bernhardt R, Schüler S, Scharnweber D, Beckmann F, Saftig P, Kollias G, Schett G, Wiederanders B, Bräuer R.

Arthritis Rheum. 2008 Feb;58(2):422-34. doi: 10.1002/art.23224.

PMID:
18240253
[PubMed - indexed for MEDLINE]
Free Article
19.

Clinicopathologic challenge. Destombes-Rosai-Dorfman disease (DRDD) (sinushistiocytosis with massive lymphadenopathy).

Becker MR, Gaiser T, Middel P, Rompel R.

Int J Dermatol. 2008 Feb;47(2):125-7. doi: 10.1111/j.1365-4632.2008.03376.x. No abstract available.

PMID:
18211480
[PubMed - indexed for MEDLINE]
20.

Immunohistochemical staining of plastic (methyl-methacrylate)-embedded bone marrow biopsies applying the biotin-free tyramide signal amplification system.

Kunze E, Middel P, Fayyazi A, Schweyer S.

Appl Immunohistochem Mol Morphol. 2008 Jan;16(1):76-82.

PMID:
18091315
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk